Literature DB >> 32208667

Biologically Responsive Plasmonic Assemblies for Second Near-Infrared Window Photoacoustic Imaging-Guided Concurrent Chemo-Immunotherapy.

Rong Zhu1, Lichao Su1, Jiayong Dai1, Zhan-Wei Li2, Shumeng Bai3, Qingqing Li1, Xiaoyuan Chen4, Jibin Song1, Huanghao Yang1.   

Abstract

We developed dual biologically responsive nanogapped gold nanoparticle vesicles loaded with immune inhibitor and carrying an anticancer polymeric prodrug for synergistic concurrent chemo-immunotherapy against primary and metastatic tumors, along with guided cargo release by photoacoustic (PA) imaging in the second near-infrared (NIR-II) window. The responsive vesicle was prepared by self-assembly of nanogapped gold nanoparticles (AuNNPs) grafted with poly(ethylene glycol) (PEG) and dual pH/GSH-responsive polyprodug poly(SN38-co-4-vinylpyridine) (termed AuNNP@PEG/PSN38VP), showing intense PA signal in the NIR-II window. The effect of the rigidity of hydrophobic polymer PSN38VP on the assembled structures and the formation mechanism of AuNNP@SN38 Ve were elucidated by computational simulations. The immune inhibitor BLZ-945 was encapsulated into the vesicles, resulting in pH-responsive release of BLZ-945 for targeted immunotherapy, followed by the dissociation of the vesicles into single AuNNP@PEG/PSN38VP. The hydrophilic AuNNP@PEG/PSN38VP nanoparticles could penetrate deep into the tumor tissues and release the anticancer drug SN38 under the reductive environment. A PA signal in the NIR-II window in the deep tumor region was obtained. The BLZ-945-loaded vesicle enabled enhanced PA imaging-guided concurrent chemo-immunotherapy efficacy, inhibiting the growth of both primary tumors and metastatic tumors.

Entities:  

Keywords:  amphiphilic nanogapped gold nanoparticles; chemo-immunotherapy; photoacoustic imaging; polymeric prodrug; second NIR window

Mesh:

Substances:

Year:  2020        PMID: 32208667     DOI: 10.1021/acsnano.9b07984

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  8 in total

Review 1.  State of the Art in Carbon Nanomaterials for Photoacoustic Imaging.

Authors:  Moon Sung Kang; Haeni Lee; Seung Jo Jeong; Tae Joong Eom; Jeesu Kim; Dong-Wook Han
Journal:  Biomedicines       Date:  2022-06-10

Review 2.  Activatable NIR-II organic fluorescent probes for bioimaging.

Authors:  Xiaoning Zhang; Shasha Li; Huizhen Ma; Hao Wang; Ruiping Zhang; Xiao-Dong Zhang
Journal:  Theranostics       Date:  2022-04-11       Impact factor: 11.600

Review 3.  Gold nanoparticles to enhance ophthalmic imaging.

Authors:  Fang Chen; Peng Si; Adam de la Zerda; Jesse V Jokerst; David Myung
Journal:  Biomater Sci       Date:  2020-10-15       Impact factor: 6.843

4.  Design of ZIF-based hybrid nanoparticles with hyaluronic acid-augmented ROS behavior for dual-modality PA/NIR-II FL imaging.

Authors:  Botao Qu; Yahong Han; Juan Li; Qian Wang; Bingyu Zhao; Xiaoyang Peng; Ruiping Zhang
Journal:  RSC Adv       Date:  2021-01-27       Impact factor: 3.361

Review 5.  Tumor immunotherapy and multi-mode therapies mediated by medical imaging of nanoprobes.

Authors:  Yang Xuan; Meng Guan; Shubiao Zhang
Journal:  Theranostics       Date:  2021-05-25       Impact factor: 11.556

Review 6.  Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?

Authors:  Shiyi Zuo; Jiaxuan Song; Jingxuan Zhang; Zhonggui He; Bingjun Sun; Jin Sun
Journal:  Theranostics       Date:  2021-06-01       Impact factor: 11.556

Review 7.  Smart Nanoparticles for Chemo-Based Combinational Therapy.

Authors:  Binita Shrestha; Lijun Wang; Eric M Brey; Gabriela Romero Uribe; Liang Tang
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.525

8.  A tumor microenvironment responsive nanosystem for chemodynamic/chemical synergistic theranostics of colorectal cancer.

Authors:  Liying Wang; Jingya Xia; Hongjie Fan; Min Hou; Huiyang Wang; Xiaoyan Wang; Ke Zhang; Liping Cao; Xiangrui Liu; Jun Ling; Hong Yu; Xia Wu; Jihong Sun
Journal:  Theranostics       Date:  2021-08-18       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.